{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:42:10Z","timestamp":1791250930945,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41433-026-04483-4","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:20:16Z","timestamp":1777389616000},"page":"1490-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-285X","authenticated-orcid":false,"given":"Nathan","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokulan","family":"Ratnarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3991-7479","authenticated-orcid":false,"given":"Jason","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Spaulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Vermorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-2116","authenticated-orcid":false,"given":"Nir","family":"Shoham-Hazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lubeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"crossref","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12:e11686.","DOI":"10.7759\/cureus.11686"},{"key":"4483_CR2","doi-asserted-by":"publisher","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","volume":"128","author":"SJ Gedde","year":"2021","unstructured":"Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, et al. Primary open-angle glaucoma preferred practice pattern. Ophthalmology. 2021;128:P71\u2013P150.","journal-title":"Ophthalmology"},{"key":"4483_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/vision7030054","volume":"7","author":"M Balas","year":"2023","unstructured":"Balas M, Mathew DJ. Minimally invasive glaucoma surgery: a review of the literature. Vision. 2023;7:54.","journal-title":"Vision"},{"key":"4483_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/j.jcrs.0000000000001537","volume":"50","author":"JM Micheletti","year":"2024","unstructured":"Micheletti JM, Brink M, Brubaker JW, Ristvedt D, Sarkisian SR. Standalone interventional glaucoma: evolution from the combination-cataract paradigm. J Cataract Refract Surg. 2024;50:1284\u201390.","journal-title":"J Cataract Refract Surg"},{"key":"4483_CR5","doi-asserted-by":"crossref","unstructured":"Funke CM, Ristvedt D, Yadgarov A, Micheletti JM. Interventional glaucoma consensus treatment protocol. Expert Rev. Ophthalmol. 2025;20:79\u201387.","DOI":"10.1080\/17469899.2025.2465330"},{"key":"4483_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2020;127:477\u201383.","journal-title":"Ophthalmology"},{"key":"4483_CR7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","volume":"111","author":"K Nouri-Mahdavi","year":"2004","unstructured":"Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627\u201335.","journal-title":"Ophthalmology"},{"key":"4483_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153:1\u20139.e2.","journal-title":"Am J Ophthalmol"},{"key":"4483_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79637-z","volume":"14","author":"S Lee","year":"2024","unstructured":"Lee S, Park DY, Huh MG, Cha SC. Influence of preoperative glaucoma medication on long-term outcomes of trabeculectomy. Sci Rep. 2024;14:28341.","journal-title":"Sci Rep"},{"key":"4483_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.007","volume":"229","author":"TW Samuelson","year":"2021","unstructured":"Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, et al. Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject\u00ae pivotal trial. Am J Ophthalmol. 2021;229:220\u20139.","journal-title":"Am J Ophthalmol"},{"key":"4483_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874364101004010052","volume":"4","author":"M Goel","year":"2010","unstructured":"Goel M, Picciani RG, Lee RK, Bhattacharya SK. Aqueous humor dynamics: a review. Open Ophthalmol J. 2010;4:52\u201359.","journal-title":"Open Ophthalmol J"},{"key":"4483_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jcrs.2012.03.025","volume":"38","author":"ER Craven","year":"2012","unstructured":"Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339\u201345.","journal-title":"J Cataract Refract Surg"},{"key":"4483_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","volume":"118","author":"TW Samuelson","year":"2011","unstructured":"Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459\u201367.","journal-title":"Ophthalmology"},{"key":"4483_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/IJG.0000000000000808","volume":"26","author":"J Buffet","year":"2017","unstructured":"Buffet J, Brasnu E, Baudouin C, Labb\u00e9 A. Efficacy of 2 trabecular micro-bypass stents during phacoemulsification for mild to advanced primary open-angle glaucoma controlled with topical hypotensive medications. J Glaucoma. 2017;26:1149\u201354.","journal-title":"J Glaucoma"},{"key":"4483_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jcrs.2017.02.029","volume":"43","author":"TJ Ferguson","year":"2017","unstructured":"Ferguson TJ, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma. J Cataract Refract Surg. 2017;43:622\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"4483_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1056573","volume":"2016","author":"P Arriola-Villalobos","year":"2016","unstructured":"Arriola-Villalobos P, Martinez-de-la-Casa JM, Diaz-Valle D, Morales-Fernandez L, Fernandez-Perez C, Garcia-Feijoo J. Glaukos iStent inject\u00ae trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study. J Ophthalmol. 2016;2016:1\u20137.","journal-title":"J Ophthalmol"},{"key":"4483_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40123-018-0152-8","volume":"7","author":"FH Hengerer","year":"2018","unstructured":"Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in eyes with various types of glaucoma. Ophthalmol Ther. 2018;7:405\u201315.","journal-title":"Ophthalmol Ther"},{"key":"4483_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12325-014-0095-y","volume":"31","author":"L Voskanyan","year":"2014","unstructured":"Voskanyan L, Garc\u00eda-Feijo\u00f3 J, Belda JI, Fea A, J\u00fcnemann A, Baudouin C. Prospective, unmasked evaluation of the iStent\u00ae inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31:189\u2013201.","journal-title":"Adv Ther"},{"key":"4483_CR19","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/OPTH.S524956","volume":"19","author":"M Inatani","year":"2025","unstructured":"Inatani M, Kohama I, Chu A. Two-year post-market surveillance of iStent inject\u00ae W combined with phacoemulsification in Japanese open-angle glaucoma eyes. Clin Ophthalmol. 2025;19:1863\u201376.","journal-title":"Clin Ophthalmol"},{"key":"4483_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","volume":"127","author":"IIK Ahmed","year":"2020","unstructured":"Ahmed IIK, Fea A, Au L, Ang RE, Harasymowycz P, Jampel HD, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma. Ophthalmology. 2020;127:52\u201361.","journal-title":"Ophthalmology"},{"key":"4483_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(01)01006-5","volume":"109","author":"BA Smit","year":"2002","unstructured":"Smit BA, Johnstone MA. Effects of viscoelastic injection into Schlemm\u2019s canal in primate and human eyes. Ophthalmology. 2002;109:786\u201392.","journal-title":"Ophthalmology"},{"key":"4483_CR22","doi-asserted-by":"crossref","unstructured":"Patel S, Reiss G. Long-term clinical and safety outcomes of canaloplasty performed across all grades of glaucoma severity. J Ophthalmol. 2023;2023:1\u20138. https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2023\/5625990.","DOI":"10.1155\/2023\/5625990"},{"key":"4483_CR23","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1007\/s10792-021-01891-1","volume":"41","author":"K Gillmann","year":"2021","unstructured":"Gillmann K, Aref A, Niegowski LJ, Baumgartner J-M. Combined Ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol. 2021;41:3295\u2013301.","journal-title":"Int Ophthalmol"},{"key":"4483_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10792-024-03322-3","volume":"44","author":"MA Khaimi","year":"2024","unstructured":"Khaimi MA, Harvey BJ, Hsueh J, Leal C, Baykal A. Canaloplasty via an ab-interno surgical technique in patients with primary angle closure glaucoma. Int Ophthalmol. 2024;44:401.","journal-title":"Int Ophthalmol"},{"key":"4483_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ogla.2022.02.007","volume":"5","author":"MJ Gallardo","year":"2022","unstructured":"Gallardo MJ. 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma. 2022;5:476\u201382.","journal-title":"Ophthalmol Glaucoma"},{"key":"4483_CR26","first-page":"251584142110457","volume":"13","author":"MA Khaimi","year":"2021","unstructured":"Khaimi MA. Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Ther Adv Ophthalmol. 2021;13:251584142110457.","journal-title":"Ther Adv Ophthalmol"},{"key":"4483_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/OPTH.S441113","volume":"18","author":"MA Khaimi","year":"2024","unstructured":"Khaimi MA, Koerber N, Ondrejka S, Gallardo MJ. Consistency in standalone canaloplasty outcomes using the iTrack microcatheter. Clin Ophthalmol. 2024;18:173\u201383.","journal-title":"Clin Ophthalmol"},{"key":"4483_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/IJG.0000000000002311","volume":"33","author":"N Koerber","year":"2024","unstructured":"Koerber N, Ondrejka S. 6-year efficacy and safety of iTrack ab-interno canaloplasty as a stand-alone procedure and combined with cataract surgery in primary open angle and pseudoexfoliative glaucoma. J Glaucoma. 2024;33:176\u201382.","journal-title":"J Glaucoma"},{"key":"4483_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/APO.0000000000000294","volume":"9","author":"K Gillmann","year":"2020","unstructured":"Gillmann K, Mansouri K. Minimally invasive glaucoma surgery: where is the evidence? Asia Pac J Ophthalmol. 2020;9:203\u201314.","journal-title":"Asia Pac J Ophthalmol"},{"key":"4483_CR30","unstructured":"Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis: The CV Mosby Co; 1993."},{"key":"4483_CR31","unstructured":"Glaukos Corporation. iStent inject\u00ae W. Available at: https:\/\/www.glaukos.com\/glaucoma\/products\/istent-inject-w\/ [Accessed February 19, 2025]."},{"key":"4483_CR32","unstructured":"Shaarawy TM, Sherwood MB, Grehn F, editors. Guidelines on Design and Reporting of Surgical Trials - World Glaucoma Association. Amsterdam: Kugler Publications; 2009."},{"key":"4483_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2024.07.030","volume":"132","author":"SJ Gedde","year":"2025","unstructured":"Gedde SJ, Vinod K, Bowden EC, Kolomeyer NN, Chopra V, Challa P, et al. Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery. Ophthalmology. 2025;132:141\u201353.","journal-title":"Ophthalmology"},{"key":"4483_CR34","first-page":"1","volume":"105","author":"European Glaucoma Society","year":"2021","unstructured":"European Glaucoma Society. European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105:1\u2013169.","journal-title":"Br J Ophthalmol"},{"key":"4483_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09286586.2017.1320413","volume":"25","author":"G-S Ying","year":"2018","unstructured":"Ying G-S, Maguire MG, Glynn R, Rosner B. Tutorial on biostatistics: statistical analysis for correlated binary eye data. Ophthalmic Epidemiol. 2018;25:1\u201312.","journal-title":"Ophthalmic Epidemiol"},{"key":"4483_CR36","unstructured":"Weinreb RN, World Glaucoma Association. Progression of glaucoma: the 8th consensus report of the World Glaucoma Association, Weinreb RN (ed). Paris: Kugler Publications; 2011."},{"key":"4483_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/eye.2016.139","volume":"30","author":"SZ Tan","year":"2016","unstructured":"Tan SZ, Au L. Manchester iStent study: 3-year results and cost analysis. Eye. 2016;30:1365\u201370.","journal-title":"Eye"},{"key":"4483_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/OPTH.S187272","volume":"13","author":"CI Clement","year":"2019","unstructured":"Clement CI, Howes F, Ioannidis AS, Shiu M, Manning D. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study. Clin Ophthalmol. 2019;13:491\u20139.","journal-title":"Clin Ophthalmol"},{"key":"4483_CR39","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.3390\/jcm12175711","volume":"12","author":"K Go\u0142aszewska","year":"2023","unstructured":"Go\u0142aszewska K, Obuchowska I, Konopi\u0144ska J. First-generation iStent bypass implantation versus ab externo canaloplasty combined with phacoemulsification in patients with primary open angle glaucoma\u201412-month follow-up. J Clin Med. 2023;12:5711.","journal-title":"J Clin Med"},{"key":"4483_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/IJG.0000000000000248","volume":"25","author":"F Yuan","year":"2016","unstructured":"Yuan F, Schieber AT, Camras LJ, Harasymowycz PJ, Herndon LW, Allingham RR. Mathematical modeling of outflow facility increase with trabecular meshwork bypass and Schlemm canal dilation. J Glaucoma. 2016;25:355\u201364.","journal-title":"J Glaucoma"},{"key":"4483_CR41","first-page":"984","volume":"45","author":"M Hee","year":"2004","unstructured":"Hee M, Conston S, Yamamoto R. Outflow facility after 180 degree catheterization and distal expansion of Schlemm\u2019s Canal in perfused cadaver eyes. Invest Ophthalmol Vis Sci. 2004;45:984.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4483_CR42","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12325-024-02788-y","volume":"41","author":"FH Hengerer","year":"2024","unstructured":"Hengerer FH, Auffarth GU, Conrad-Hengerer I. 7-year efficacy and safety of iStent inject trabecular micro-bypass in combined and standalone usage. Adv Ther. 2024;41:1481\u201395.","journal-title":"Adv Ther"},{"key":"4483_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1248","volume":"12","author":"M Popovic","year":"2018","unstructured":"Popovic M, Campos-Moller X, Saheb H, Ahmed IIK. Efficacy and adverse event profile of the iStent and iStent inject trabecular micro-bypass for open-angle glaucoma: a meta-analysis. J Curr Glaucoma Pract. 2018;12:67\u201384.","journal-title":"J Curr Glaucoma Pract"},{"key":"4483_CR44","doi-asserted-by":"crossref","unstructured":"Koerber N, Ondrejka S. Clinical outcomes of canaloplasty via an ab-interno surgical technique using the iTrack device: a narrative review. Int Ophthalmol. 2022;43:2017\u201327. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36445546 [Accessed September 21, 2023].","DOI":"10.1007\/s10792-022-02601-1"},{"key":"4483_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ophtha.2020.11.004","volume":"128","author":"IIK Ahmed","year":"2021","unstructured":"Ahmed IIK, Rhee DJ, Jones J, Singh IP, Radcliffe N, Gazzard G, et al. Three-year findings of the HORIZON trial: a Schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract. Ophthalmology. 2021;128:857\u201365.","journal-title":"Ophthalmology"},{"key":"4483_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40123-019-00208-x","volume":"8","author":"D Manning","year":"2019","unstructured":"Manning D. Real-world case series of istent or istent inject trabecular micro-bypass stents combined with cataract surgery. Ophthalmol Ther. 2019;8:549\u201361.","journal-title":"Ophthalmol Ther"},{"key":"4483_CR47","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s12325-019-01067-5","volume":"36","author":"RAP Guedes","year":"2019","unstructured":"Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. One-year comparative evaluation of iStent or iStent inject implantation combined with cataract surgery in a single center. Adv Ther. 2019;36:2797\u2013810.","journal-title":"Adv Ther"},{"key":"4483_CR48","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.4103\/ijo.IJO_308_21","volume":"69","author":"WS Shalaby","year":"2021","unstructured":"Shalaby WS, Lam S, Arbabi A, Myers J, Moster M, Kolomeyer N, et al. iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucoma. Indian J Ophthalmol. 2021;69:2488.","journal-title":"Indian J Ophthalmol"},{"key":"4483_CR49","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.survophthal.2017.08.006","volume":"63","author":"M Masis","year":"2018","unstructured":"Masis M, Mineault PJ, Phan E, Lin SC. The role of phacoemulsification in glaucoma therapy: a systematic review and meta-analysis. Surv Ophthalmol. 2018;63:700\u201310.","journal-title":"Surv Ophthalmol"},{"key":"4483_CR50","doi-asserted-by":"crossref","unstructured":"Khoo PY, Tang SF, Lam C, Cheng TC, Din NM. One-Year comparative analysis between standalone iStent implantation versus combined iStent implantation with phacoemulsification. Eur J Ophthalmol. 2024;35:611\u20137.","DOI":"10.1177\/11206721241273678"},{"key":"4483_CR51","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s40123-024-00984-1","volume":"13","author":"TH Neuhann","year":"2024","unstructured":"Neuhann TH, Neuhann RT, Hornbeak DM. Ten-year effectiveness and safety of trabecular micro-bypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension. Ophthalmol Ther. 2024;13:2243\u201354.","journal-title":"Ophthalmol Ther"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04483-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:03:14Z","timestamp":1783440194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04483-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04483-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NK, KB, JS, JC, NSH, SP, DL are consultants to Nova Eye Medical. GR, SP, JC, KB, KW, JW are consultants to Glaukos. DL was a consultant of Glaukos in the past. KB and NK are the founders of the IGSR. Writing and editorial support were provided by GP Communications and funded by Nova Eye Medical: the funder bore the cost associated, but was not involved with the data collection, analysis, or interpretation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The IGSR (International Glaucoma Surgery Registry), which stores the data used in this study, was approved by ethics committee WCG IRB (approval number 20200728) and was registered in the Australian New Zealand Clinical Trials Registry (ACTRN trial number 12620001021965). Data is anonymised with the use of unique codes for each patient, with participating surgeons using only the codes to track patient records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}